Exosomes derived from umbilical cord mesenchymal stem cells alleviate jaw bone marrow mesenchymal stem cells senescence and restore osteogenic differentiation potential

Aug 28, 2025Stem cell research & therapy

Umbilical cord stem cell exosomes reduce aging and restore bone-forming ability in jaw bone stem cells

AI simplified

Abstract

UCMSC-Exos treatment significantly reduced in jaw bone marrow mesenchymal stem cells.

  • Treatment with UCMSC-Exos decreased the number of senescent cells in JBMMSCs, indicated by reduced SA-β-gal-positive cells.
  • Key proteins associated with cellular senescence (p53, p21, p16) and inflammatory markers (IL-6, TNF-α) were downregulated following treatment.
  • Improvements in cellular functions such as proliferation, migration, and osteogenic differentiation were observed in UCMSC-Exos-treated JBMMSCs compared to controls.
  • UCMSC-Exos restored autophagy in JBMMSCs by modulating the PI3K/AKT/mTOR signaling pathway.
  • In aged rat models, UCMSC-Exos treatment enhanced bone repair in calvarial defects.

AI simplified

Key numbers

13.83±3.07%
Bone Volume/Total Volume in Aged Rats
Bone volume in the Aged + Exo group after UCMSC-Exos treatment
6
SA-β-gal-positive Cells Reduction
Number of experimental replicates for SA-β-gal staining
5
Calcium Deposition Increase
Number of experimental replicates for osteogenic differentiation assays

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free